Similar articles

• Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.

  Holmes EL. Holmes EL. Ann Phys Med. 1966;Suppl:36-49. Ann Phys Med. 1966. PMID: 4895006 Clinical Trial. No abstract available.
• [Ionized fluorine in the plasma and urine of subjects treated with organofluorine drugs prescribed in rheumatology].

  Boiteau HL, Prost A, Rossel-Renac F, Audran M, Hamelin JP, Carlier N. Boiteau HL, et al. Rev Rhum Mal Osteoartic. 1979 Feb;46(2):123-32. Rev Rhum Mal Osteoartic. 1979. PMID: 34870 French.
• [Clinical results in the treatment of rheumatic diseases using flufenamic acid].

  Peña González A. Peña González A. Rev Esp Reum Enferm Osteoartic. 1968 Oct;12(8):217-8. Rev Esp Reum Enferm Osteoartic. 1968. PMID: 5307372 Spanish. No abstract available.
• [Collateral and toxic effects of non-steroid antirheumatic drugs].

  Fossati C. Fossati C. Clin Ter. 1979 Aug 15;90(3):273-305. Clin Ter. 1979. PMID: 399874 Review. Italian. No abstract available.
• A rheumatologist's view of nonsteroidal anti-inflammatory drugs.

  Moore ME. Moore ME. Clin Ther. 1981;4(3):137-49. Clin Ther. 1981. PMID: 7030488 Review. No abstract available.